Synopsis: Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Companies
-
-
AgrochemicalsBioNTechGlobal Market
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50%
by adminby adminSummary : In just two short years, BioNTech will have more than doubled the size of its workforce at the German biologics…
-
CompaniesGlobal MarketPfizerPharma Science & Research
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…
-
Biocon PharmaceuticalCompaniesGlobal Market
Biocon Biologics set to reap Biosimilar Insulin Glargine Opportunity in US
by adminby adminSummary : Drugmaker is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit…
-
AgrochemicalsGlobal MarketSanofi Inc.
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
by adminby adminSynopsis : Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates…
-
AgrochemicalsBristol Myers Squibb
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says
by adminby adminSummary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
-
CompaniesGlobal MarketNovartis
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
by adminby adminSynopsis : Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial(1) that compared single intravenous doses of ensovibep,…
-
Bharat BiotechCompanies
Bharat Biotech seeks full marketing approval from DCGI for Covaxin
by adminby adminSynopsis : Bharat Biotech has sought from the Drugs Controller General of India (DCGI) regular market approval for its COVID-19 vaccine Covaxin’,…
-
CompaniesEli Lilly
JPM 2022: Eli Lilly gears up for Alzheimer’s-diabetes juggling act as 2 key FDA decisions loom
by adminby adminSummary : On the brink of two major approvals this year, Eli Lilly is laser-focused on diabetes and dementia. One market is…
-
AgrochemicalsAstraZenecaGlobal Market
AstraZeneca sells another half-million doses of its COVID-19 antibody combo to the US
by adminby adminSummary : Order up. Shortly after topping off supplies of COVID-19 drugs from Pfizer and GlaxoSmithKline, the U.S. has asked for a…